Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Drug-resistant bacteria producing a resistance factor, TetA efflux pump (in red), during treatment with tetracycline antibiotic (in green).  Photo: Christian Lesterlin/MMSB department, University of Lyon, France

Using technology with real-time viewing, a team of scientists say in Science Thursday they can now show how quickly E. coli becomes resistant to tetracycline — finding that bacteria can pass genes with resistance to each other and then use a pump to keep most of the antibiotic out for the 2 hours it takes to render the previously sensitive bacteria resistant to the drug.

Why it matters: Antibiotic resistance is a growing threat that's projected to kill 10 million people every year by 2050. The discovery of how it occurs, at least in a lab setting, could help scientists develop an inhibitor that could be combined with an antibiotic to boost its effectiveness, study co-author Christian Lesterlin tells Axios.

What they did: During the 4-year project, the team first developed a system to monitor the transfer of DNA between cells.

  • They added a resistance gene to the transferred DNA to look at how quickly resistance was established.
  • Using live-cell microscopy, they tracked what the cells did in real-time. This was key to seeing how the process unfolded, says Lesterlin, who's a researcher at the University of Lyon in France.
  • "With our system, we can look at things happening in real-time, describe the chronology, the time scale and learn about the genetic factors ... and the influence of antibiotics on this process," he says.

What they found, per Lesterlin:

  • The bacterium can become resistant in less than 2 hours after getting the new genetic material: "It all happens very quickly."
  • The role of the multidrug efflux pump is "essential" to the acquisition of new resistance by gene transfer between the E. coli.
  • Even when the antibiotic tetracycline is present, the cells use the pump to export the antibiotics from the cell and "buy time for the cell" to acquire resistance.
  • "The most surprising result was to observe that even in the presence of protein synthesis inhibitors (tetracycline antibiotic ), sensitive cells are still able to acquire the DNA, but more surprisingly they are still able to develop the resistance."

What they're saying: ETH Zurich's Vanessa R. Povolo and Martin Ackermann write in an accompanying perspective piece that the findings offer what could be an "important element" in the fight against antibacterial resistance — that the development of pump inhibitors will be key.

"Inhibitors of bacterial efflux pumps are receiving a lot of attention because they often make bacteria more sensitive to antibiotics. This study shows that these inhibitors could have a second, indirect, effect: They could block the transfer of resistance between bacteria during treatment. As a consequence, they could limit the emergence of new resistant strains," they write.

What's next: Lesterlin says their study is limited because it's only been conducted in the lab, so they hope to perform follow up tests in mammals, as well as testing other antibiotics or with other bacteria to see if they have similar responses. "Transferring this finding to the gut microbiota would be an important step forward."

Go deeper:

Go deeper

Brazil begins distributing AstraZeneca coronavirus vaccine

Containers carrying doses of the Oxford/AstraZeneca vaccine arrive in Brazil. Photo: Maurio Pimentel/AFP via Getty Images

Brazil on Saturday began distributing the 2 million doses of the AstraZeneca coronavirus vaccine that arrived from India Friday, Reuters reports.

Why it matters: Brazil has the third highest COVID-19 case-count in the world, according to Johns Hopkins University data. The 2 million doses "only scratch the surface of the shortfall," Brazilian public health experts told the AP.

Sullivan speaks with Israel's national security adviser for the first time

Israeli national security adviser Meir Ben Shabbat U.S. Photo: Mazen Mahdi/Getty Images. U.S. national security adviser Jake Sullivan. Photo: Chandan Khanna/Getty Images

U.S. national security adviser Jake Sullivan spoke on the phone Saturday with his Israeli counterpart Meir Ben Shabbat, Israeli officials tell Axios.

Why it matters: This is the first contact between the Biden White House and Israeli prime minister's office. During the transition, the Biden team refrained from speaking to foreign governments.

Biden speaks to Mexican president about reversing Trump's "draconian immigration policies"

Mexican President Andrés Manuel López Obrador. Ismael Rosas/Eyepix Group/Barcroft Media via Getty Images

President Biden told his Mexican counterpart, Andrés Manuel López Obrador, on a phone call Friday that he plans to reverse former President Trump’s “draconian immigration policies.”

The big picture: The Biden administration has already started repealing several of Trump’s immigration policies, including ordering a 100-day freeze on deporting many unauthorized immigrants, halting work on the southern border wall, and reversing plans to exclude undocumented people from being included in the 2020 census.